U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene
SAN CARLOS, Calif.–(BUSINESS WIRE)–$BGNE #BeiGene—BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends... Read more.
Vacasa Stockholders Approve Merger with Casago
PORTLAND, Ore.–(BUSINESS WIRE)–Vacasa, Inc. (Nasdaq: VCSA) (“Vacasa” or the “Company”), a leading vacation rental management... Read more.
ISEE and TICO Announce Strategic Partnership to Deliver Industry-First Fully Integrated Autonomous Yard Trucks to Customer Operations
CAMBRIDGE, Mass.–(BUSINESS WIRE)–ISEE, a leading provider of autonomous driving solutions, and TICO, a top manufacturer of terminal tractors, today announced... Read more.
American Pride Bank Welcomes Dominik Mjartan as Chief Executive Officer
Bank’s Total Assets Grow by 46%, Crossing $540M in Six Months ATLANTA–(BUSINESS WIRE)–American Bancorp Inc. is proud to formally announce the... Read more.
10th Annual MITRE eCTF Competition Cultivates Future Cybersecurity Leaders
MCLEAN, Va. & BEDFORD, Mass.–(BUSINESS WIRE)–#cybersecurity–At an award celebration at Tufts University, MITRE honored the winners, participants,... Read more.
Informa TechTarget Recognized for Leadership in Multiple 2025 Account-Based Marketing (ABM) Reports
The Company’s comprehensive intent-driven services and strategic partnerships are delivering significant account-based outcomes for customers NEWTON, Mass.–(BUSINESS... Read more.
SOTIO Reports Promising Preclinical Data on Antibody-Drug Conjugates SOT109 and SOT106, Underscoring Best-in-Class Potential for Solid Tumor Treatments
SOT109 (targeting cadherin-17) exhibits potent efficacy and a favorable safety profile in preclinical models of colorectal cancer; currently in IND-enabling stage... Read more.
Innate Pharma Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 at the AACR 2025 Annual Meeting
IPH4502 is a differentiated exatecan ADC targeting Nectin-4, currently investigated in a Phase 1 clinical trial in advanced solid tumors. IPH4502 demonstrated superior... Read more.
AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
Preclinical data on AbCellera’s PSMA x CD3 T-cell engagers demonstrate potent anti-tumor activity and potential to further enhance function through costimulatory... Read more.
NexusOne Consulting Launches to Lead the Future of Policy in Emerging Tech, Crypto, and AI
Better insights. Better impact. WASHINGTON–(BUSINESS WIRE)–Today marks the official launch of NexusOne Consulting, a results-driven government relations... Read more.